Univercells SA
Ouverture de faillite 83.6 FTEUnivercells reported total assets of €231.6m at the end of the 2023 financial year (annual accounts filed with the NBB on 11 Jul 2024), with 83.6 full-time equivalents.
The score of Univercells shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Equity +261 % Total assets +244 % Headcount (avg FTE) +39 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Univercells's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
- Year ended 31 Dec 2020filed on 22 Jun 2021
- Year ended 31 Dec 2019filed on 24 Jun 2020
Univercells's financial analysis
- Solvency61.7%sector median: 42.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Univercells
Univercells's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0502.742.288
- VAT number
- BE0502742288
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 24 Jan 2013
- Registered office
- 6040 Charleroi
- Size
- Medium · 83.6 FTE
- Latest accounts
- 2023 · filed on 11 Jul 2024
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Univercells (SA) has been based in Charleroi since 2013, active in: manufacture of other pharmaceutical products. For 2023, it reports a net profit of €20.4m and equity of €142.8m; its revenue is not published. With 83.6 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 61.7%, above the median of its sector (42.6%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Univercells
Companies in the same business, of comparable size and area, outside its group.
- MDxHealth Research and experimental development on natural sciences and engineering Herstal · balance sheet €159.3m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
- A.forall Development Manufacture of pharmaceutical preparations Anderlecht · balance sheet €71.3m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- Ncardia Holding Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €108.4m
- Genzyme Flanders Manufacture of pharmaceutical preparations Geel · balance sheet €1.00bn
Frequently asked questions about Univercells
What is the revenue of Univercells?
Univercells files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of Univercells?
In Belgium, the VAT number is the company number prefixed with BE: BE0502742288 for Univercells, if the company is VAT-registered. Its company number (CBE) is 0502.742.288.
Where is the registered office of Univercells?
According to the CBE register, the registered office of Univercells is in 6040 Charleroi.
What is the equity of Univercells?
At the close of the 2023 financial year, the equity of Univercells amounts to 142,840,848 €, a solvency of 61.7% of total assets.
How many people work at Univercells?
83.6 full-time equivalents on average according to the 2023 social balance sheet.
Who manages Univercells?
The register lists 12 active mandates at Univercells. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Univercells
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →